Peroxiredoxin I expression in oral cancer: a potential new tumor marker
Toru Yanagawa(University of Tsukuba), Hiroshi Yoshida(Jikei University School of Medicine), Hiroshi Yusa(University of Tsukuba), Tetsuro Ishii(University of Tsukuba), Hiroyuki Harada(Tokyo Medical and Dental University), Haruhiko Suzuki(Tohoku University), Satoshi Iwasa(University of Tsukuba), Kojiro Onizawa(University of Tsukuba), Ken Omura(Ebina General Hospital), Katsuhiko Tabuchi(Shinshu University)
Cited by 112
Related Papers
Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
|Cancer Research|2008|618
Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma
|International Journal of Clinical Oncology|2014|263
The Tumor Suppressive MicroRNA <i>miR-218</i> Targets the mTOR Component <i>Rictor</i> and Inhibits AKT Phosphorylation in Oral Cancer
|Cancer Research|2011|250
Differential binding properties of B7-H1 and B7-DC to programmed death-1
|Biochemical and Biophysical Research Communications|2003|206
The Novel Gene Encoding a Putative Transmembrane Protein Is Mutated in Gnathodiaphyseal Dysplasia (GDD)
|The American Journal of Human Genetics|2004|175